Stay updated with breaking news from Genalyte Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,...
/PRNewswire/ -- The "Global Lab-on-a-Chip Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global lab-on-a-chip market is...
Share this article Share this article ResearchAndMarkets.com's offering. The Global Biochip Market is expected to grow at an impressive rate of around 15% during the forecast period. The Global Biochip Market is driven by the growing prevalence of various chronic and infectious disease especially in the geriatric population who are more susceptible to these diseases on account of low immunity. This has led to the increase in the demand for personalized medicine solutions or targeted therapies especially for treating diseases like cancer. This in turn is expected to positively influence the m...
Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform Diagnostic and Analytics Company Aims to Revolutionize Laboratory Testing and Analytics News provided by Share this article SAN DIEGO, Jan. 11, 2021 /PRNewswire/ -- Genalyte, a leading diagnostics and analytics company, announced today the closure of $50 million in financing. Genalyte's Maverick™ Diagnostic System (MDS) uses silicon chip based photonic ring resonance technology to perform multiple, simultaneous, rapid tests on a small volume of whole blood or serum in twenty minutes....